Craig Chepke, MD, DFAPA

  • 5Articles
  • 47.8KReads
  • 2023–2025Active
  • 23Collaborators
  • 107Citations

About

Craig Chepke, MD, DFAPA, is affiliated with Excel Psychiatric Associates in Huntersville, North Carolina. His publications from 2023 to 2025 focus on sleep disorders, including idiopathic hypersomnia and obstructive sleep apnea, as well as the effects of lemborexant on insomnia. He has also contributed to research on neuropsychiatric conditions such as major depressive disorder, schizophrenia, Alzheimer disease, posttraumatic stress disorder, and movement disorders, examining topics like noradrenergic dysregulation and benztropine usage patterns. Chepke has frequently collaborated with co-authors including Ruth M. Benca and Andrew D. Krystal.

Publications

JCP
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice
Narrative Review

Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice

June 2, 2025

Idiopathic hypersomnia, characterized by excessive daytime sleepiness (EDS), has an estimated population prevalence up to 1.5%. Psychiatric medications may exacerbate EDS and, conversely, idiopathic hypersomnia treatments may exacerbate psychiatric...
, , , et al
PCC
Impact of Lemborexant on Daytime Functioning
Original Research

Impact of Lemborexant on Daytime Functioning

January 16, 2025

Improved insomnia symptoms with lemborexant treatment may translate into improved daytime functioning.
, , , et al
JCP
Dysregulation of Noradrenergic Activity
Academic Highlights

Dysregulation of Noradrenergic Activity

November 8, 2024

Dysregulation of noradrenergic activity plays a key role in symptom presentation in major depressive disorder, schizophrenia, Alzheimer’s agitation, and PTSD. This article provides an expert panel’s consensus regarding the...
, , , et al
PCC
Benztropine Usage Patterns in Movement Disorders
Original Research

Benztropine Usage Patterns in Movement Disorders

August 29, 2023

This study evaluated real-world treatment patterns for patients initiating benztropine and examined treatment approaches in patients with drug-induced movement disorders from a health care provider perspective.
, , , et al
JCP
Managing Obstructive Sleep Apnea in Psychiatric Practice
Systematic Review

Managing Obstructive Sleep Apnea in Psychiatric Practice

January 23, 2023

As shown in this review, OSA may be a risk factor for the development of psychiatric conditions, as well as suicidal ideation and attempts.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe